Table 2.

Visual outcome

	Control N (%)	Surgically Treated Glaucoma, N (%)	Medically Treated Glaucoma, N (%)	Total N (%)	P*
Pre-op BCVA (n)	59	34	14	107
≥20/25	6 (10.2)	1 (2.9)	1 (7.1)	8 (7.5)	0.52
≥20/40	27 (45.8)	3 (8.8)	2 (14.3)	32 (29.9)	0.0002
≥20/200	53 (89.8)	18 (52.9)	8 (57.1)	79 (73.8)	<0.0001
Post-op BCVA†	59	34	14	107
≥20/25, n (%)	46 (78.0)	11 (32.4)	10 (71.4)	67 (62.6)	<0.0001
≥20/40, n (%)	52 (88.1)	18 (52.9)	13 (92.9)	83 (77.6)	0.0002
≥20/200, n (%)	59 (100)	29 (85.3)	14 (100)	102 (95.3)	0.0054
Change in BCVA from pre-op to post-op (eyes)
Improved, n (%)	55 (93.2)	29 (85.3)	14 (100)	98 (91.6)	0.24
Unchanged (eyes), n (%)	4 (6.8)	5 (11.8)	0 (0)	9 (8.4)
Worsened (eyes), n (%)	0 (0)	0 (0)	0 (0)	0 (0)
P-value

BCVA = best corrected visual acuity

^†Post-operative BCVAever achieved.

^*Fisher exact test